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Abstract (250 words) 
A functioning placental renin angiotensin system (RAS) appears necessary for uncomplicated 
pregnancy and is present during placentation, which occurs under low oxygen tensions. Placental 
RAS is increased in pre-eclampsia (PE), characterised by placental dysfunction and elevated 
oxidative stress. We investigated the effect of high-altitude hypoxia on the RAS and hypoxia-
inducible factors (HIFs) by measuring mRNA and protein expression in term placentae from 
normotensive (NT) and PE women who delivered at sea level or above 3100m; using an explant 
model of hypoxia-reoxygenation to assess the impact of acute oxidative stress on the RAS and 
HIFs. Protein levels of prorenin (P=0.049), prorenin receptor (PRR; P=0.0004), and angiotensin 
receptors (AT1R, P=0.006) and (AT2R, P=0.002) were all significantly higher in placentae from 
NT women at altitude, despite mRNA expression being unaffected. However, mRNA expression 
of all RAS components was significantly lower in PE at altitude than at sea level, yet PRR, 
angiotensinogen (AGT) and AT1R proteins were all increased. The increase in transcript and 
protein expression of all the HIFs and NADPH oxidase 4 seen in PE compared to NT at sea-level 
was blunted at high altitude. Experimentally-induced oxidative stress stimulated AGT mRNA 
(P=0.04) and protein (P=0.025). AT1R (r=0.77, P<0.001) and AT2R (r=0.81, P<0.001) mRNA 
both significantly correlated with HIF-1β, whilst AT2R also correlated with HIF-1α (r=0.512, 
P<0.013). 
Our observations suggest that the placental RAS is responsive to changes in tissue oxygenation: 
this could be important in the interplay between reactive oxygen species as cell-signalling 
molecules for angiogenesis and hence placental development and function. 
 
 
Abbreviations: AGT, angiotensinogen; Ang II, angiotensin II; Ang IV, angiotensin IV; Ang (1-
7), angiotensin-(1-7); AT1R, angiotensin type 1 receptor; AT2R, angiotensin type 2 receptor; 
AT2AR, adenosine A2A receptor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HA, high 
altitude; HIF, hypoxia-inducible factor; NOX4, NADPH oxidase 4; H/R, hypoxia-reperfusion; 
NT, normotensive; PE, pre-eclampsia; PRR, prorenin receptor; RAS, renin–angiotensin system; 
ROS, reactive oxygen species; XO, xanthine oxidase.  
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Introduction 
In the early 20
th
 century, Sir Joseph Barcroft (Barcroft, 1946) famously postulated that the fetus 
may be considered as ‘Everest in utero’  because of its development in an hypoxic environment 
equivalent to that probably only experienced at the Earth’s highest point– the summit of Mount 
Everest.  
The transition from acute hypoxia to hypoxic adaptation may involve the renin angiotensin system 
(RAS), which has been known as a regulator of systemic blood pressure and vascular function for 
many decades, reviewed in (Nguyen Dinh Cat & Touyz, 2011; Farag et al., 2015). The systemic 
RAS in male adults is activated by acute exposure to high altitude (Sun et al., 2013) whereas 
exposure to chronic hypoxia in rat models of primary hypertension causes the RAS to be 
suppressed (Cervenka et al., 2015).  
The RAS may play a significant role in differing ways throughout pregnancy for example, in the 
early stages of placentation. Components such as the angiotensin receptors are expressed at very 
early stages of embryogenesis (Tebbs et al., 1999; Pijacka et al., 2012) and in the placental 
syncytiotrophoblast and cytotrophoblast  (Williams et al., 2010), where they may be responding to 
maternally-derived angiotensin II (Ang II).  Both Ang II and the biologically-active fragment 
Angiotensin IV (3-8) (Ang IV) promote the invasion and proliferation of trophoblasts (Williams et 
al., 2010) and angiogenesis in placental tissue, thus supporting the establishment of a placental 
vasculature. Development of the yolk sac placenta in explanted rat embryos is highly-significantly 
increased by Ang II (Tebbs et al., 1999).  Prorenin and angiotensinogen (AGT) proteins are 
detected in the syncytiotrophoblast and cytotrophoblasts as early as 6 weeks gestation (Marques et 
al., 2011; Pringle et al., 2011) with prorenin also being found in the extravillous trophoblasts and 
AGT in the villous stroma.   
Detailed knowledge on the process of implantation in humans is scarce. One fact is unequivocal: 
trophoblast invasion clearly correlates with oxygenation of the placenta (Huppertz et al., 2014). 
Initial reorganisation of the syncytiotrophoblast layer and proliferation of the underlying 
cytotrophoblasts occurs in the first 5 weeks after implantation under oxygen tensions below 20 
mmHg (Rodesch et al., 1992; Jauniaux et al., 2000; Jauniaux et al., 2001). These oxygen tensions 
in other tissues would be considered ‘hypoxic’ but are physiologically normal for establishment of 
the placenta (Cindrova-Davies et al., 2015). The oxygen tension in the underlying decidua basalis 
at this time is ~60 mmHg, and so the extravillous trophoblast invasion occurs along an oxygen 
gradient. Indirect measurements of oxygen tension , using aspirates in the intervillous space, 
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indicate that in the second half of normal pregnancy oxygen tensions decline, from 60 mmHg at 
18 weeks gestation to 30-40 mmHg at term (Soothill et al., 1986) . 
In normal pregnancy, placental growth is stimulated by a number of factors including adenosine, 
which promotes angiogenesis, proliferation, inflammation and protection against oxidative stress 
(Hasko & Cronstein, 2004). We have previously established that there is a strong positive 
association between the RAS and adenosine in first trimester placental tissue (Kurlak et al., 2015) 
when oxygen tensions are low (Rodesch et al., 1992; Jauniaux et al., 2001). The stimulation of 
adenosine is a response to hypoxia (Poth et al., 2013) and therefore unsurprisingly placental 
adenosine receptor A2AR strongly correlates with HIF-1α (Kurlak et al., 2015). Is the RAS acting 
as a signal transduction regulator for both oxygen sensing and angiogenesis? In other cell systems, 
such as human fibroblasts, co-operativity between hypoxia- and angiotensin-induced proliferative 
responses has already been observed (Krick et al., 2005), but a relationship between the RAS and 
the low oxygen environment in the placenta has not yet been investigated. 
The RAS has also been well researched in the context of hypertensive disorders of pregnancy such 
as pre-eclampsia (PE) (Symonds et al., 1975; Irani & Xia, 2011)  which is defined as de novo 
hypertension after 20 weeks gestation with significant proteinuria (Brown et al., 2001; Tranquilli 
et al., 2013).  It has previously been suggested that in PE, the placental tissue is more hypoxic 
than in normotensive pregnancy. Since there are no direct measurements of intervillous oxygen 
tension beyond early second trimester, these assumptions have largely been based on evidence 
such as upregulation of global gene expression in PE showing similarities to in vitro and in vivo 
models of placental hypoxia (Soleymanlou et al., 2005) and increases in hypoxia-inducible factors 
(HIFs) (Zamudio et al., 2007; Rajakumar et al., 2008) . These assumptions are being questioned 
in light of up-to-date evidence (Huppertz et al., 2014), where placental metabolism in PE shows 
that there is no reduction in energy supplies as would be expected in chronic hypoxia (Bloxam et 
al., 1987). It has been proposed (Hung & Burton, 2006) that the absolute oxygen concentration in 
the intervillous space may not be critically important, but rather fluctuations in oxygen tension 
that may lead to tissue oxidative stress as indicated by rapid degeneration of syncytium (Watson et 
al., 1998). Sharp rises in oxygen tension within the lobule could induce excessive bursts of 
production of reactive oxygen species (ROS), which include free radicals such as superoxide 
anions, nitric oxide and hydroxyl radicals (Hung et al., 2001). Bursts of ROS production that 
overwhelm local antioxidant defences will result in oxidative stress. PE is characterised by both 
increased circulatory and placental oxidative stress (reviewed in (Goulopoulou & Davidge, 2015). 
There are several sources within the placental tissue that could generate ROS bursts, including 
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mitochondria. These have been proposed as a source of the oxidative stress in PE, as demonstrated 
by swelling and loss of cristae, increased concentrations of malondialdehyde showing greater 
potential for lipid peroxidative damage (Wang & Walsh, 1998).  
The formation of excessive amounts of free radicals and hence failure of mitochondrial reduction-
oxidation balance have been tightly linked to dysregulation in the RAS (Vajapey et al., 2014).  
One of the main peptides generated from AGT substrate is Ang II, which binds with equal affinity 
to its type 1 (AT1R) and type 2 (AT2R) receptors (de Gasparo et al., 2000). The binding of Ang II 
to AT1R activates NADPH oxidase (NOX), which leads to increased generation of cytoplasmic 
ROS. This Ang II-AT1R-NADPH-ROS signal triggers the opening of mitochondrial potassium 
(KATP) channels and mitochondrial ROS production in a positive feedback loop (Vajapey et al., 
2014). The maintenance of ROS balance means that the production of ROS needs to be matched 
with ROS scavenging mechanisms: Ang II has been implicated not only in activating ROS but 
also in decreasing the activity of scavenging enzymes (decreasing glutathione peroxidase, 
superoxide dismutase and catalase), thereby contributing even further to detrimental levels of 
ROS (Vajapey et al., 2014).  
Our group has already suggested a role for RAS components in the establishment of the placenta 
by demonstrating temporal changes in the Ang II receptors - AT1R, AT2R,  AT4R (the receptor 
for bioactive Ang IV  peptide) through gestation, and a temporal relationship with the pro-oxidant 
enzymes – NADPH oxidase isoform (NOX4) and xanthine oxidase (XO) (Williams et al., 2010). 
Furthermore, the placental RAS is altered in PE with angiotensin receptor type 1 (AT1R) being 
more highly expressed in the placenta from women with PE than from normotensive women 
(Mistry et al., 2013). AT1R expression negatively correlates with infant birthweight and placental 
glutathione peroxidase 3 protein (Mistry et al., 2013).  
Pregnancy at high altitude offers a unique opportunity to investigate the effects of chronic hypoxia 
on the placenta and PE has an increased incidence at high altitude  being three-fold greater in 
areas above 2500 m (Moore et al., 2011).  
On the basis of these considerations, we therefore hypothesised that (i) the placental RAS would 
be activated by high altitude hypoxia; ii) that these changes would be magnified in placentae from 
pre-eclamptic mothers; iii) that oxidative stress induced by hypoxia/reperfusion (H/R) injury 
might be the activator of the RAS as opposed to hypoxia per se. 
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We tested this by examining (i) placentae from normotensive women who had delivered at high 
altitudes compared to those who resided at sea-level before and throughout the pregnancy;  (ii) 
placentae from PE pregnancies at altitude compared to women with PE at sea-level.  In addition, 
(iii) we cultured term placental tissue explants in vitro under differing conditions of hypoxia and 
oxidative stress.  
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Methods 
Ethical approval 
All samples were collected following provision of informed, written consent conforming to the 
standards set by the Declaration of Helsinki, and all procedures were approved by the local ethics 
committee (Hospital Ethics Committee of the Nottingham University hospitals, University of 
Colorado Health Sciences Center (Aurora, CO, USA) and University College Hospital London 
(London, UK), and the Cambridge Local Research Ethics Committee). 
Subjects, selection criteria and sample collection 
Normotensive control and PE placentae were collected from women at both sea-level and high 
altitude. PE was stringently defined as per the International Society for the Study of Hypertension 
in Pregnancy guidelines of a systolic blood pressure of 140 mm Hg or more and diastolic pressure 
(Korotkoff V) of 90 mm Hg or more on 2 occasions after 20 weeks gestation in a previously 
normotensive woman and proteinuria ≥300 mg/L, ≥500 mg/day or ≥2+ on dipstick analysis of 
midstream urine if 24-hour collection result was not available (Brown et al., 2001). Exclusion 
criteria included smoking, renal disease, cardiac disease, diabetes, chronic hypertension, 
pregnancy-induced hypertension, or any other complications of pregnancy, and known risk factors 
for these conditions. All placentae were from term deliveries, either by elective Caesarean section 
or vaginal delivery. The high altitude placentae were collected at St. Vincent's General Hospital 
(Leadville, CO, USA; 3100 m) from stable, but recently migrant, populations of European 
descent. The sea-level placentae were collected at the Rosie Hospital (Cambridge, UK) and, 
Nottingham University Hospitals (Nottingham, UK) and University College Hospital (London, 
UK). By the very nature of the collections, the subject numbers differed in the various parts of the 
study and will be specified with the results. 
Samples were obtained using a systematic random system by which the placenta was divided into 
5 areas (Hung et al., 2001). Two full-thickness samples were taken from each area, washed in 
phosphate buffered saline (PBS) to remove blood contamination, snap-frozen in liquid nitrogen 
within 10 min of delivery, and maintained at −80°C until further processed. Samples for 
immunohistochemistry were immediately submersed in formalin to be fixed for 12–24 h. After 
being treated with 70% ethanol for 24 h, placental samples were further dissected before being 
embedded in paraffin wax. 
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Acute hypoxia experiments 
Villous samples were taken midway between the chorionic and basal plates, from the periphery of 
lobules free of visible infarction, calcification, haematoma or tears.  After a brief rinse in cold 
PBS, samples were placed into ice-cold transport medium (TCS large vessel endothelial cell basal 
medium (TCS CellWorks, Milton Keynes, UK), containing 2% fetal bovine serum, heparin, 
hydrocortisone, human epidermal growth factor, human basic fibroblast growth factor, 25 μg/ml 
gentamicin and 50 ng/ml amphotericin B, 1 mM vitamin C and 1 mM Trolox) that had been 
equilibrated with 5% O2/90% N2/5% CO2, as described before  (Cindrova-Davies et al., 2007).  
 
Following transport to the laboratory on ice, placental samples were further dissected into small 
pieces (about 5 mm in diameter) in ice-cold culture medium, in a glove box under 10% O2/85% 
N2/5% CO2. Samples were cultured on individual Costar Netwell (24 mm diameter, 500 μm mesh) 
supports in 4 ml culture medium per well in 6-well plates.  Approximately 6-10 pieces were added 
to each well, depending on the experimental requirements.  Placental explants were incubated in 
pre-gassed medium under: i) normoxic conditions (controls) (10% O2/85% N2/5% CO2), ii) 
treatment with 1mM H2O2 under normoxia, or iii) conditions of repetitive hypoxia±reoxygenation 
(HR - repetitive cycles of 0.5% O2/94.5% N2/5% CO2 for 6 hr and 10 % O2/85% N2/5% CO2 for 6 
hr) in the ExVivo system (BioSpherix, NY, USA) for 24 hr.  The Biospherix incubator was 
calibrated before each experiment and set to maintain the normoxic cultures under 10%O2, 5% 
CO2 in order to mimic the oxygen concentration within the term placenta (Soothill et al., 1986).  
 
RNA extraction and cDNA synthesis 
Total RNA was extracted from a known amount of placental tissue (~100 mg) using QIAzol lysis 
reagent (Qiagen, Crawley, UK) as previously described (Mistry et al., 2011). RNA concentration 
and purity were verified spectrophotometrically using the Nanodrop ND-1000 (Nanodrop 
Technologies, Labtech, Ringmer, UK); all of the samples had an A260/A280 ratio >1.96. RNA (1 
μg) was reverse transcribed using the QuantiTect Reverse Transcription kit (Qiagen, Crawley, 
UK) in a Primus96 thermocycler (Peqlab Ltd, Fareham, UK).  
Quantitative real time Polymerase Chain Reaction (PCR) 
Real-time PCR was carried out using SYBR Green chemistry (2x QuantiFast SYBR Green, 
Qiagen, Crawley, UK) on a ABI7500 Fast (Life Technologies,UK) using the primers detailed in 
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Table 1. Melt-curve analysis was performed to confirm the presence of one single product and 
non-template controls were run to assess contamination. The standard curve method was used to 
quantify gene expression. Abundance data for the genes of interest were expressed following 
normalisation using GeNORM (http://medgen.ugent.be/~jvdesomp/genorm/), with 3 stably 
expressed housekeeping genes, suitable for human placental samples: GAPDH, β-2-microglobulin 
and β-actin (Murthi et al., 2008; Kurlak et al., 2013) and expressed normalised to copy number. 
Immunohistochemical staining of RAS components and markers of hypoxia/oxidative stress 
Placental protein expression was analysed by immunohistochemistry. Serial sections of placental 
tissue were cut (5 µm) in the same orientation from paraffin-embedded tissue blocks (Sledge 
Microtome, Anglia Scientific, Norwich, UK) and mounted onto Superfrost Plus glass microscope 
slides (Menzel-Glaser, Braunschweig, Germany). Before use, sections were dewaxed by 
immersion in xylene followed by rehydration in descending concentrations of alcohol.  
Immunohistochemical staining was performed using the Dako Envision staining kits (Dako Ltd 
Germany). Eight rabbit and 2 mouse antibodies were used for immunostaining of paraffin-
embedded placental sections. The optimal dilutions and details of all antibodies used are shown in 
Table 2. Heat-induced epitope retrieval was achieved by heating in a citrate buffer (pH 6.0) using 
a microwave oven for 15 minutes (800 W), followed by incubation for 30 minutes in normal goat 
serum (Sigma-Aldrich, UK) to block nonspecific binding; slides were then incubated with primary 
antibodies overnight at 4°C. A negative control was performed for each test section by incubation 
with mouse or rabbit IgG as appropriate. Specificity of antibodies was verified by Western blot 
analysis with identification of the target protein confirmed by specific bands of correct molecular 
weight (data not shown). Sections were dehydrated and cleared in ascending concentrations of 
alcohol and xylene before mounting in DPX (BDH, Poole, United Kingdom). 
For analysis of placental sections, digital images of 5 randomly selected, high-power fields (Nikon 
Eclipse II microscope,×400 magnification) were captured using NIS-Elements F2.20 (Nikon UK 
Ltd, UK). Protein expression was semi-quantitatively assessed (H-score) by two blinded observers 
(LOK & HDM), as described previously (Mistry et al., 2013). Between-observer agreement for H-
scoring was excellent (kappa 0.97). A visual check was also performed to ensure accurate 
discrimination of immunolabelled regions. 
 
Statistical analysis 
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All tests were performed using SPSS for Windows version 22 and GraphPad PRISM, version 6. 
Summary data are presented as means ± standard deviation (SD) or median and interquartile range 
(IQR) as appropriate.  One-way ANOVA or Kruskal-Wallis tests followed by Gabriel’s or Mann-
Whitney U post hoc tests were used depending on the distribution of the data, after testing using 
the Kolmogorov-Smirnov test. Correlations between the parameters were tested with a 
Spearman’s Rank test. The null hypothesis was rejected where P<0.05. The data from the in vitro 
culture experiments were evaluated using repeated measures analysis.  
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Results 
A. Ex vivo data 
(i). Placental RAS in normotensive women at high altitude 
mRNA measurements were available from 9 placentae collected at sea-level (spontaneous vaginal  
delivery (SVD, n=4); elective Caesarean section (CS, n=5) and 8 at high altitude (CS, n=4; SVD, 
n=4). For the protein expression study, 16 placentae were collected at sea level n=16, (SVD, n=9; 
CS, n=7), and 8 at high altitude (SVD, n=4; CS, n=4). 
The mRNA expression of all RAS components was not significantly affected by altitude in 
normotensive women, although variation was higher for all components at high altitude (Fig.1A). 
In contrast, the protein levels of prorenin (P = 0.049), prorenin receptor (PRR; P = 0.0004) and 
both AT1R (P = 0.006) and AT2R (P = 0.002) were all significantly higher in the high-altitude 
placentae (Fig. 1B), although AGT was not different (P > 0.1). All proteins were confined to the 
outer layer of the villous syncytiotrophoblast. The ratio between prorenin and its receptor, 
(PRR/prorenin) also rose significantly (P = 0.008): sea level median 0.34 [IQR 0.1-0.6]; high 
altitude median 0.86 [0.75-0.93] whilst that between the AT1R and AT2R was unchanged (P > 
0.8): sea level median 0.97 [IQR 0.79-1.4]; high altitude median 0.96 [0.82-1.30]. The mode of 
delivery did not influence protein expression of any of the RAS components (P > 0.2 to > 0.7) and 
therefore we did not consider this as a confounder in further analyses.   
 
(ii). Placental RAS in women with PE at high altitude 
mRNA measurements were available from 19 placentae collected at sea-level (n=11) and at high 
altitude (n=8). Samples analysed for proteins included 6 collected at sea-level and 5 at high 
altitude.   
The mRNA expression was significantly lower in placentae from pre-eclamptic women at high 
altitude for all RAS components (Fig. 1A), except the AT1R. In contrast with samples from 
normotensive women , the variability in mRNA expression was also markedly less. However, the 
protein levels of PRR, AGT and AT1R were all increased in PE at altitude (Fig. 1B) although this 
only reached statistical significance for AGT and AT1R. 
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Placental HIFs and NOX4 in normotensive and PE pregnancies at high altitude  
In the normotensive pregnancies, placental mRNA expression of all HIFs and NOX4 was 
unaffected by altitude (Fig. 2A). However, the protein level of all the HIFs: HIF-1α (P< 0.001); 
HIF-1β (P < 0.001); HIF-2α (P = 0.04) as well as NOX4 (P = 0.001) was significantly raised in 
high altitude pregnancies (Fig. 2B). Immunohistochemical staining localised the proteins to the 
syncytiotrophoblast and around the fetal vessels of the placental villi. The enzyme XO, was 
unaffected by altitude (data not shown). 
The effect of altitude on the pattern of expression differed in the placentae from women with PE. 
Whereas there was no effect of altitude in the normotensive women, the placental mRNA 
expression of HIF-1α, HIF-1β and NOX4 mRNA expression were all lowered at high altitude 
compared to the sea-level PE women (P < 0.001 for all; Fig. 2A). When comparing placentae 
from normotensive and PE women at sea-level, HIF-1α and NOX4 mRNA expression was 
markedly higher in the PE compared to normotensive controls (P = 0.01 and P = 0.001 
respectively). At high altitude, HIF-2α mRNA expression was lower in PE than the normotensive 
group (P = 0.003; Fig. 2A).  
Placental protein levels were equally affected by altitude in the PE women: HIF-1α (P < 0.01); 
HIF-1β (P = 0.03); HIF-2α (P = 0.017) as well as NOX4 (P = 0.004) were significantly lower in 
high altitude pregnancies in women with PE (Fig. 2B). XO protein was not altered (data not 
shown). 
In high-altitude samples, protein levels of HIF-1α (P = 0.001); HIF-1β (P = 0.001); HIF-2α (P = 
0.029) and NOX4 (P = 0.019) were significantly lower in women with PE as compared to 
normotensive women (Fig. 2B). 
 
B. In vitro data 
(i) In vitro explant culture under experimental oxidative stress conditions  
Due to the nature of the explant methodology, sample numbers in each of the treatment groups 
were 4-6 depending on availability of sufficient quality tissue. Oxidative stress was induced by 
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subjecting explants to repetitive cycles of hypoxia-reoxygenation for 24 hr, or by treating explants 
with hydrogen peroxide under normoxia.      
Experimental hypoxia/reperfusion treatment significantly increased the mRNA expression of only 
AGT (P = 0.04) compared to normoxic conditions. Protein expression followed the same pattern 
(AGT, P = 0.025; Fig. 3).  Treatment with hydrogen peroxide under normoxic oxygen 
concentrations had no effect on AGT mRNA, although both hydrogen peroxide and 
hypoxia/reperfusion were associated with significantly-increased AGT protein (Fig. 3). No other 
components of the RAS were significantly altered by any of the treatments.  
The HIFs and antioxidant enzymes were also measured in these experiments, to establish whether 
hypoxia was being sensed within this model. There was no observable effect of these 
experimental conditions on either mRNA expression or protein of any of the HIFs, NOX4, or XO. 
Interestingly, we identified strong positive correlations in gene expression between HIF-1β and 
both angiotensin receptors AT1R (r = 0.77, P < 0.001) and AT2R (r = 0.81, P < 0.001), but only 
AT2R also correlated with HIF-1α (r = 0.512, P < 0.013; Fig. 4). 
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Discussion 
Our aim was to investigate the effects of various forms of oxidative stress on the RAS in the 
human placenta, including exposure to the lower pO2 of high altitude chronic hypoxia, the 
elevated tissue and circulatory chronic oxidative stress which characterises PE, and the acute 
experimental oxidative stress induced in vitro by hypoxia/reperfusion or hydrogen peroxide 
insults. Our results demonstrate, for the first time, that components of the RAS are activated under 
these conditions. Furthermore, we show that the type of component activated and the degree of 
activation are dependent on the nature of the insult. 
At high altitude, there is a generalised, significant increase in activity of the placental RAS, 
which, to our knowledge, has not been reported previously. The rise in PRR protein is statistically 
highly significant. Binding of (pro) renin to this receptor induces a 4-fold increase in its catalytic 
efficiency in the generation of angiotensin I (Ang I) from AGT (Nguyen et al., 2002). Thus, 
changes in receptor expression can have a substantial effect on the generation rate of Ang I, and 
hence Ang II, even without changes in AGT. Furthermore, our results from the in vitro hypoxia-
reperfusion model show a significant increase in both mRNA and protein expression of AGT, 
supporting our premise that this element of the renin-angiotensin axis may be instrumental in 
‘tuning’ the regulation of the placental RAS in a redox environment. When oxidised AGT is 
reacted with renin in the presence of the PRR, there is a 4-fold increase in the generation of Ang I 
(in addition to the 4-fold increase induced by the binding of prorenin to the receptor), which does 
not occur if reduced AGT is reacted (Zhou et al., 2010). The hypobaric hypoxia of high altitude 
might be sufficient to increase the ratio of oxidised: reduced AGT and further stimulate the 
system. This appears to be corroborated by the rise in AGT observed after an acute hypoxic insult 
in the experimental model. Our observations suggest that this increase in AGT is not simply a 
reaction to lower oxygen tension per se, but potentially relates to the increased oxidative stress 
induced by this model (Cindrova-Davies et al., 2007). We could only examine total AGT 
expression, as it is not yet possible to distinguish the oxidised and reduced forms 
immunohistochemically; total expression was not different at the two altitudes. 
Low concentrations of endogenous ROS are important in the activation of signalling pathways 
which relate to adaptations to hypoxia, such as genes involved in angiogenesis (e.g. VEGF),  
where the promoter region has a binding site for hydrogen peroxide (Oshikawa et al., 2010), 
which is essential for full activation of VEGF receptor 2 (VEGFR2).  Accumulating evidence 
points towards the existence of direct interactions between Ang II and VEGF; a recent study has 
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demonstrated that AT2R mediates the synergistic effect of a combination of Ang II and VEGF-A 
to promote differentiation of  bone marrow-derived mesenchymal stem cells into endothelial cells 
(Ikhapoh et al., 2015). These authors suggest that AT2R could be critical to repair and regenerate 
damaged vascular endothelium. In other cell systems, such as mouse Lewis lung carcinoma cells, 
hypoxia appears to upregulate ACE, Ang II, and AT1R. Most intriguingly, this regulation is 
diphasic:  in the early phase, after 6 hr hypoxia, AT1R protein is decreased, whilst AT2R protein 
is increased; yet if hypoxia is continued up to 24 hr this effect is reversed, with AT1R protein 
significantly increased and AT2R decreased (Fan et al., 2014). Employing specific 
pharmacological inhibitors, these authors concluded that this diphasic response may be due to a 
bi-directional control mechanism: hypoxia enhances the expression of AT1R and AT2R via 
increased Ang II, but elevated AT2R inhibits AT1R during the early stage whilst AT1R inhibits 
AT2R expression as hypoxia continues. This may explain why neither the AT1R nor the AT2R 
were significantly altered in our hypoxia/reperfusion model. Similarly, Cindrova-Davies et al 
reported increased HIF-1α protein in placental explants when challenged with hypoxia/reperfusion 
for only 7h (Cindrova-Davies, 2009) but these changes were no longer evident after a longer, 24h 
period.  
HIF-1β knockout mice die in midgestation having reduced levels of VEGF protein and increased 
numbers of apoptotic hematopoietic cells (Ramirez-Bergeron et al., 2006) : HIF coordinates early 
endothelial cell emergence and vessel development by promoting hematopoietic cell survival and 
paracrine growth factor production. Thus the strong association, observed in this study (Fig.4), 
between the angiotensin receptors and oxygen-sensing proteins, HIF-1β and HIF-1α, adds 
credence to the idea that these receptors are involved in the oxygen sensing mechanism of the 
syncytiotrophoblast. As expression of AT2R is highest early in pregnancy, the association we 
have found with both HIF-1 α and HIF-1β oxygen-sensing units, supports a possible role for RAS 
in normal placental development. 
AT2R may also have a protective role in the repair of oxygenation-induced damage (Namsolleck 
et al., 2014), as seen in ischaemic stroke (McCarthy et al., 2009), myocardial ischaemic injury 
(Parlakpinar et al., 2011; Park et al., 2013)  and neurological pathologies (Sumners et al., 2013). 
By the same token, prorenin has been shown to stimulate proliferation of retinal endothelial cells 
to an equivalent degree as that induced by VEGF, and independently of Ang II (Zhu et al., 2015). 
In pancreatic cancer cells, Ang II induces VEGF, through AT1R and ERK1/2 signalling 
(Anandanadesan et al., 2008). Studies in AGT-knockout mice report blunted hypoxia-induced 
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endothelial progenitor cell function, indicating that AGT is required for hypoxia-induced 
vasculogenesis (Choi et al., 2014). 
Since hypoxia stimulates the release of ROS, we postulated that the low oxygen partial pressure 
at altitude (hypobaric hypoxia) would amplify the oxidative stress of PE through increased 
production of ROS, and thus augment the stimulation of the RAS already observed in PE at sea-
level. However, this stimulation did not occur. Whereas mRNA expression of the RAS was 
unaffected in normotensive women at high altitude (Fig. 1A), it was reduced in PE placentae at 
high altitude (Fig. 1A).  However, translation followed a very different pattern, showing 
increased translation (protein expression) in a majority of components of the RAS, in both 
normotensive and PE women at high altitude.   
Concurrent analysis of the mRNA expression of the HIFs (Fig. 2) revealed that there were no 
detectable differences between sea-level and high altitude placentae in the normotensive women; 
this agrees with previously published data (Tissot van Patot et al., 2004).  In contrast, the 
increases in HIF-1α, and NOX4 observed in PE compared to normotensive women at sea-level 
were not observed in PE at altitude; indeed, the mRNAs encoding HIF-1, HIF-1β and NOX4 
were significantly lower in placentas from PE women at high altitude. Our protein data (Fig. 2) 
expand the study of Zamudio et al (Zamudio et al., 2007), which reported increases in the HIF-
1α protein expression at high altitude in normotensive women. However, the observation that 
placental responses to oxygen deprivation are completely blunted at high altitude in women with 
PE, as demonstrated by the lower mRNA and protein parameters of all the HIFs, is completely 
novel. Despite the low sample numbers, these observed differences are striking. This certainly 
begs the question – do pregnant women who develop PE at altitude have an adaptive response to 
hypoxia that differs to that of normotensive women?  In healthy pregnancies at altitude, placental 
HIF activity is reduced as seen by lower HIF-1/DNA binding despite unchanged HIF protein 
levels (Tissot van Patot et al., 2004); placentae at high altitude display little evidence of 
oxidative stress following labour normally seen in laboured placentae at low altitude (Tissot van 
Patot et al., 2010). Rajakumar et al. (Rajakumar et al., 2008) suggest that impairment of protein 
degradation, rather than increased synthesis causes inadequate oxygen-dependent reduction of 
HIF-1α protein in PE and is supported by the fact that, in early-onset PE placentae at least, there 
is decreased expression of the prolyl hydroxylases, PHD1 and PHD2 (Rolfo et al., 2010). Hence, 
molecular events leading to the formation of the HIF-1α:VHL-ubiquitin ligase complex (Ivan et 
al., 2001), as well as proteasomal trypsin, chymotrypsin, and peptidyl glutamyl-like activities 
may be the focus of adaptation. In well-oxygenated cells, PHDs hydroxylate the HIF-1α 
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subunits, thereby targeting them for proteosomal degradation and resulting in a half-life of less 
than 5 minutes (Wang et al., 1995). PHDs are the key enzymes triggering HIF-1 α 
desensitization, a feedback mechanism required to protect cells against necrotic cell death and 
thus to adapt them to chronic hypoxia (Ginouves et al., 2008). Whereas humans living at low 
altitudes ordinarily maintain low levels of HIF-1α and HIF-2α through constitutive 
hydroxylation and degradation, upon ascent to high altitude attenuated PHD2 hydroxylase 
activity due to hypoxia leads to increased levels of HIF-1α and HIF-2α. Even so, the Tibetan 
population shows the strongest support for the hypothesis that multiple genes in the HIF pathway 
can be reconfigured in response to chronic hypoxia (Bigham & Lee, 2014); (Lorenzo et al., 
2014):  the most convincing candidates for this reconfiguration being PHD2 and HIF-2α.  
Tibetans are the first humans in whom a hypo-responsive HIF system has been demonstrated, 
and may represent an evolutionary resetting of the HIF system to operate within a hypoxic 
environment (Petousi et al., 2014). However, this may differentiate populations long-
acclimatised to life at high altitude from those relatively-recently arrived, such as the inhabitants 
of Colorado included in this study. 
As noted in the Introduction, deficient spiral artery remodelling may lead to a hypoxia/reperfusion 
insult. In order to explore the possibility that oxidative stress and not hypoxia per se, is the driving 
force behind the activation of the RAS at high altitude and in PE, we used the fully-validated 
experimental model of hypoxia/reperfusion. In this model, increased oxidative stress is 
demonstrated by the increase in heat shock proteins Hsp27 and Hsp90, lipid peroxidation and 
formation of peroxynitrite (Cindrova-Davies et al., 2007) localised mainly to the 
syncytiotrophoblast. Under these acute conditions of oxidative stress, our study reveals a more 
specific stimulation of the RAS, as seen by increased mRNA and protein expression of AGT only 
(Fig. 3).  The fact that other RAS components were not increased by the acute oxidative stress of 
these experimental conditions implies that their generalised stimulation at high altitude may be a 
response to the chronically-reduced oxygen tensions. This is supported by the fact that in a mouse 
model of alveolar hypoxia, such as may occur in pulmonary diseases (e.g. chronic obstructive 
pulmonary disease), the RAS is stimulated by the low pO2 (Gonzalez & Wood, 2010) and it is the 
activation of  NOX by the RAS that leads to an inflammatory response. However, if the animals 
remain under hypoxic conditions  for several days, the inflammation resolves and exposure to 
lower pO2 does not elicit further inflammation, suggesting that the vascular endothelium has 
"acclimatised" to hypoxia (Gonzalez & Wood, 2010). Furthermore, in human lung fibroblast cells, 
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hypoxia directly activates the RAS to induce collagen type I expression, mediated by NF-κB 
signalling, which in turn activates AT1R expression (Liu et al., 2013).   
Previously, using the different methodology of  Western blotting to measure protein in term villi, 
and a shorter time period of 7 hr, hypoxia/reperfusion was found to stimulate  HIF-1 α in this 
model (Cindrova-Davies, 2009). Using the semi-quantitative method of immunohistochemical 
scoring and a longer time period of 24hr, we did not detect this stimulation. Likewise, use of 
hydrogen peroxide to mimic the effect of oxygen in acutely lowering HIF-1 α, over the longer 
24hr period, did not have the same effect as previously.  
Hypoxia cannot be merely defined by just the prevailing oxygen tension (Cindrova-Davies et al., 
2015), but must be related to the metabolic demands of the tissue. As Barcroft himself said 
“oxygen –is- but one of the proximate principles of nourishment” (Young, 1992). The placenta is 
an extremely metabolically active tissue (Carter, 2000; Illsley et al., 2010). Oxygen sensing is of 
fundamental importance to all cells as oxygen consumption is required for ATP generation (Guzy 
& Schumacker, 2006).  In tissue such as the placenta, which is exposed not only to altered oxygen 
concentrations and hypoxia/reperfusion insults during development, but also within its own 
lobular structures, oxygen sensing is critical in order to stimulate gene expression and 
transcription of genes relating to growth processes, including angiogenesis. An ability to control 
oxygen sensing mechanisms using molecules which do not disrupt oxygen consumption would 
have a profound impact on a diverse range of pathologies. We have here described such a 
potential system.  
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Figure Legends 
Figure 1: A) Normalised mRNA expression (copy number) of all RAS components in placentae 
from: normotensive controls residing and delivering at sea level (n = 9) or at high altitude (n = 8); 
pre-eclamptic women residing and delivering at sea level (n = 11) or at high altitude (n = 8).  
 B) Placental protein expression and localisation of RAS components from: normotensive controls 
residing and delivering at sea level (n = 16) or at high altitude (n = 8); pre-eclamptic women 
residing and delivering at sea level (n = 6) or at high altitude (n = 5).  
 Boxplots represent median [interquartile range]; *P<0.05; **P<0.001; ***P<0.0001. Positive 
staining (brown) was localised mainly in the syncytiotrophoblast (black arrows). All 
photomicrographs taken at x400 magnification, scale bars=100µm. PRR: prorenin receptor; AGT: 
angiotensinogen; AT1R/2R: angiotensin receptors type 1 and 2. 
Figure 2: A) Normalised mRNA expression (copy number) of all hypoxia-inducible factor (HIF) 
components and NADPH oxidase (NOX4) in placentae from normotensive controls (NT) and pre-
eclampsia (PE) residing and delivering at sea level or at high altitude. B) Placental protein 
expression and localisation of HIF components and NOX4 from NT and PE women residing and 
delivering at sea level or at high altitude. Boxplots represent median [interquartile range]; 
*P<0.05; **P<0.001; ***P<0.0001. Positive staining (brown) was localised mainly in the 
syncytiotrophoblast (black arrows), with some staining around fetal vessels (red arrows). All 
photomicrographs taken at x400 magnification, scale bars=100µm.  
Figure 3: Placental angiotensinogen A) mRNA and B) protein expression of term placental 
explants (n = 4-6) following incubation in normoxic conditions; following hydrogen peroxide 
(H2O2); after hypoxia/reperfusion (H/R). Data analysed using repeated measures analysis and are 
represented at mean ± standard deviations; **P<0.001. Positive staining (brown) was localised 
mainly in the syncytiotrophoblast (black arrows). All photomicrographs taken at x400 
magnification, scale bars=100µm. AGT: angiotensinogen. 
Figure 4: Scatter plots demonstrating associations in placental mRNA expression of AT1R, 
AT2R, HIF-1β and HIF-α. HIF-1β strongly correlated with both AT1R (r=0.77; P<0.001) and 
AT2R (r=0.81; P<0.001) under all oxygenation conditions. AT2R also correlated with HIF-1α 
(r=0.512; P<0.01). 
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Table 1. Details of primers used in qPCR. 
Gene 
Accession 
number 
                 Primers 
Length 
(bp) 
PRR 
 NM 
5’ cctcattaggaagacaaggactatcc 3’ 
50 
5’ gggttcttcgcttgttttgc 3’ 
 
Prorenin 
NM 
5’ ccacctcctccgtgatcct 3’ 
46 5’ gcggatagtactgggtgtccat 3’ 
 
AGT 
NM_000029  
5` ccccagtctgagatggctc 3` 
117 5` gacgaggtggaaggggtgta 3` 
 
AT1R NM_004835 
5’ ggctattgttcacccatgaagt 3’ 
177 5’ tgggactcataatggaaagcac 3’ 
 
AT2R 
NM_000686 
5’ tatggcctgtttgtcctcattg 3’ 
115 5’ ccattgggcatatttctcaggt 3’ 
 
HIF1α 
NM_ 181054 
5’ atccatgtgaccatgaggaaatg 3’ 
125 5’ tcggctagttagggtacacttc 3’ 
 
HIF1β 
NM_ 001197325 
5’ tgactcctgttttgaaccagc 3’ 
95 5’ ctgctcacgaagtttatccacat 3’ 
 
HIF2α 
NM_ 001430 
5’ ggacttacacaggtggagcta 3’ 
5’ tctcacgaatctcctcatggt 3’ 
 
79 
NOX4 
NM_016931.3 
5’ tgaactatgaggtcagcctctg 3’ 
107 5’ aagcttgtatggtttccagtcat 3’ 
 
GAPDH 
NM_002046.3 
5’ ggaagcttgtcatcaatggaa 3’ 
5’ tggactccacgacgtactca 3’ 
 
102 
Β-Actin 
NM_001101.2 
5’ ccaaccgcgagaagatga 3’ 
5’ ccagaggcgtacaggatag 3’ 
 
97 
B2M 
NM_004048.2 
5’ cttatgcacgcttaactatcttaacaa 3’ 
5’ taggagggctggcaacttag 3’ 
 
127 
 
   28 
 
 Table 2. Product descriptions and concentrations for immunohistochemistry 
Product name/Description  Concentration 
(mg/mL) 
PRR Anti- ATP6AP2 - Sigma Prestige, 
HPA003156.  
Rabbit polyclonal 
1.8 
Prorenin Anti-prorenin –Abcam, ab82450. 
Mouse monoclonal 
0.042 
AGT Anti-AGT – Sigma Prestige, HPA0031557.  
Rabbit polyclonal 
0.26 
AT1R Anti-AT1R – Abcam, ab9391.  
Mouse monoclonal 
80 
AT2R Anti-AT2R - Abcam, ab19134 
Rabbit ployclonal 
5.2 
HIF1α Anti- HIF1α – Sigma Prestige, HPA0031557 
Rabbit polyclonal 
0.001 
HIF1β Anti- Arnt – Aviva Systems Biology, 
ARP30979. Rabbit polyclonal 
0.001 
HIF2α Anti-EPAS1 - Aviva Systems Biology, 
ARP32253. Rabbit polyclonal 
0.005 
NOX4 Anti-NOX4 - Abcam, ab133303.  
Rabbit polyclonal 
1:500 
XDH Anti-XDH - Aviva systems biology 
OAAB05869. Rabbit polyclonal 
0.5µg/ml 
 
